Table 1.
Parameter | Value | Range | Ref. | |
---|---|---|---|---|
SnC |
Sensitivity of CMR |
0.82 |
0.77-0.86 |
[17] |
SpC |
Specificity of CMR |
0.86 |
0.82-0.89 |
[17] |
SnS |
Sensitivity of SPECT |
0.67 |
0.60-0.72 |
[17] |
SpS |
Specificity of SPECT |
0.83 |
0.79-0.86 |
[17] |
SnA |
Sensitivity of angiography |
1.00 |
N/A |
[19-21] |
SpA |
Specificity of angiography |
1.00 |
N/A |
[19-21] |
RC |
Complication rate with CMR |
0.0005 |
0.0001-0.001 |
[23] |
RS |
Complication rate with SPECT |
0.0005 |
0.0001-0.001 |
[20] |
RA |
Complication rate with angiography |
0.005 |
0.001-0.01 |
[28] |
RF |
Complication rate for patients with CAD and false-negative test results* |
0.25 |
0.15-0.30 |
[20,21] |
MC |
Mortality rate due to CMR |
0.00005 |
0.00001-0.0001 |
[20,24] |
MS |
Mortality rate due to SPECT |
0.00005 |
0.00001-0.0001 |
[20,24] |
MA |
Mortality rate due to angiography |
0.00075 |
0.0001-0.0015 |
[28] |
MF |
Mortality rate for patients with CAD and false-negative test results* |
0.20 |
0.15-0.25 |
[19,20] |
NDxC |
Rate of non-diagnostic CMR |
0.05 |
0.01-0.1 |
[17,25] |
NDxS |
Rate of non-diagnostic SPECT |
0.05 |
0.01-0.1 |
[17,25] |
NDxA |
Rate of non-diagnostic angiography |
0.00 |
N/A |
[19-21] |
CC |
Cost of CMR [in €] |
703 |
527-879 |
[31,34] |
CS |
Cost of SPECT [in €] |
504 |
378-630 |
[30,33] |
CA |
Cost of angiography [in €] |
2,926 |
2,195-3,658 |
[29,35] |
C |
Cost of a complication# [in €] |
14,478 |
10,859-18,098 |
[21,36] |
NC |
No. of patients having CMR |
1.0 |
N/A |
[21] |
NS |
No. of patients having SPECT |
1.0 |
N/A |
[21] |
NA |
No. of patients having angiography |
varies |
Equation 1a |
[19-21] |
NFC |
No. of false-negative CMR |
varies |
Equation 1a |
[19-21] |
NFS |
No. of false-negative SPECT |
varies |
Equation 1a |
[19-21] |
P |
Prevalence of CAD |
varies |
0.1-1.0 |
[19-21] |
ΔQALY’ |
QALY extended by CAD therapy* |
3.0 |
2.0-4.0 |
[20] |
ΔQALY | Net QALY gained | varies | Equations 1c,2c | [20] |
*Over a 10-year follow-up period.
#Assumed to be myocardial infarction (or cerebral, for invasive angiography).
Angiography refers to invasive coronary angiography. Details of the parameters are given in the text.
CAD: coronary artery disease; CMR: cardiovascular magnetic resonance; N/A: not applicable; QALY: quality-adjusted life-year; SPECT: single-photon emission computed tomography.